ADVANCE study : a new therapeutic strategy for type 2 diabetes?

被引：0

|

作者：

不详

机构：

来源：

DIABETES & METABOLISM | 2007年 / 33卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：1

相关论文

共 50 条

[21] Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy
M. A. Stefater
T. H. Inge
Current Diabetes Reports, 2017, 17
[22] Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?
Halimi, S
DIABETES & METABOLISM, 2001, 27 (02) : 287 - 293
[23] Immediate Triple Combination Therapy as a new Therapeutic Strategy for untreated Type 2 Diabetes Results from the TRIPLE-AXEL Study
Schamarek, Imke
DIABETOLOGIE, 2024,
[24] Vascular outcome in type 2 diabetes: an ADVANCE?
Kaplan, Norman M.
LANCET, 2007, 370 (9590): : 804 - 805
[25] Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Esser, Nathalie
Zraika, Sakeneh
DIABETOLOGIA, 2019, 62 (07) : 1113 - 1122
[26] Is a new therapeutic class justified in the treatment of type 2 diabetes?
Halimi, S
ANNALES D ENDOCRINOLOGIE, 2002, 63 (02) : S7 - S11
[27] Myokine X, a New Therapeutic Approach for Type 2 Diabetes
Bernard, Daphne
Vion-Chambrial, Julie
Pinget, Michel
Sultan, Ariane
Bouzakri, Karim
DIABETES, 2024, 73
[28] Ozempic®: a new therapeutic option for type 2 diabetes patients
Coquard-Schmidt, Barbara
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2019, 23 (4-5): : 139 - 139
[29] Type 2 diabetes mellitus pathogenesis:: new therapeutic managements?
Blicklé, JF
REVUE DE MEDECINE INTERNE, 2003, 24 (11): : 709 - 710
[30] Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Nathalie Esser
Sakeneh Zraika
Diabetologia, 2019, 62 : 1113 - 1122

← 1 2 3 4 5 →